VALBIOTIS SA (ALVAL.PA) Fundamental Analysis & Valuation

EPA:ALVAL • FR0013254851

Current stock price

1.03 EUR
+0.04 (+4.04%)
Last:

This ALVAL.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. ALVAL.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALVAL has reported negative net income.
  • In the past year ALVAL has reported a negative cash flow from operations.
  • In the past 5 years ALVAL always reported negative net income.
  • ALVAL had a negative operating cash flow in each of the past 5 years.
ALVAL.PA Yearly Net Income VS EBIT VS OCF VS FCFALVAL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5M -10M

1.2 Ratios

  • ALVAL's Return On Assets of -65.45% is on the low side compared to the rest of the industry. ALVAL is outperformed by 76.19% of its industry peers.
  • ALVAL's Return On Equity of -135.28% is on the low side compared to the rest of the industry. ALVAL is outperformed by 63.10% of its industry peers.
Industry RankSector Rank
ROA -65.45%
ROE -135.28%
ROIC N/A
ROA(3y)-46.24%
ROA(5y)-42.87%
ROE(3y)-89.86%
ROE(5y)-84.49%
ROIC(3y)N/A
ROIC(5y)N/A
ALVAL.PA Yearly ROA, ROE, ROICALVAL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

1.3 Margins

  • ALVAL does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALVAL.PA Yearly Profit, Operating, Gross MarginsALVAL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20K -40K -60K -80K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. ALVAL.PA Health Analysis

2.1 Basic Checks

  • ALVAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALVAL has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ALVAL has more shares outstanding
  • ALVAL has a worse debt/assets ratio than last year.
ALVAL.PA Yearly Shares OutstandingALVAL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
ALVAL.PA Yearly Total Debt VS Total AssetsALVAL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • ALVAL has an Altman-Z score of 1.27. This is a bad value and indicates that ALVAL is not financially healthy and even has some risk of bankruptcy.
  • ALVAL has a Altman-Z score (1.27) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 0.45 indicates that ALVAL is not too dependend on debt financing.
  • ALVAL's Debt to Equity ratio of 0.45 is in line compared to the rest of the industry. ALVAL outperforms 50.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 1.27
ROIC/WACCN/A
WACC7.25%
ALVAL.PA Yearly LT Debt VS Equity VS FCFALVAL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M

2.3 Liquidity

  • A Current Ratio of 2.85 indicates that ALVAL has no problem at all paying its short term obligations.
  • ALVAL has a Current ratio (2.85) which is comparable to the rest of the industry.
  • A Quick Ratio of 2.26 indicates that ALVAL has no problem at all paying its short term obligations.
  • ALVAL has a Quick ratio of 2.26. This is comparable to the rest of the industry: ALVAL outperforms 53.57% of its industry peers.
Industry RankSector Rank
Current Ratio 2.85
Quick Ratio 2.26
ALVAL.PA Yearly Current Assets VS Current LiabilitesALVAL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. ALVAL.PA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 15.60% over the past year.
  • Looking at the last year, ALVAL shows a very strong growth in Revenue. The Revenue has grown by 417.14%.
  • The Revenue for ALVAL have been decreasing by -21.79% on average. This is quite bad
EPS 1Y (TTM)15.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.7%
Revenue 1Y (TTM)417.14%
Revenue growth 3Y4.86%
Revenue growth 5Y-21.79%
Sales Q2Q%309.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 30.40% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, ALVAL will show a very strong growth in Revenue. The Revenue will grow by 227.80% on average per year.
EPS Next Y25.36%
EPS Next 2Y36.33%
EPS Next 3Y30.4%
EPS Next 5YN/A
Revenue Next Year438.94%
Revenue Next 2Y313.66%
Revenue Next 3Y227.8%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALVAL.PA Yearly Revenue VS EstimatesALVAL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 10M 20M 30M
ALVAL.PA Yearly EPS VS EstimatesALVAL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. ALVAL.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALVAL. In the last year negative earnings were reported.
  • Also next year ALVAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALVAL.PA Price Earnings VS Forward Price EarningsALVAL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVAL.PA Per share dataALVAL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as ALVAL's earnings are expected to grow with 30.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.33%
EPS Next 3Y30.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ALVAL.PA Dividend Analysis

5.1 Amount

  • ALVAL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ALVAL.PA Fundamentals: All Metrics, Ratios and Statistics

VALBIOTIS SA

EPA:ALVAL (4/10/2026, 7:00:00 PM)

1.03

+0.04 (+4.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-02
Earnings (Next)N/A
Inst Owners2.17%
Inst Owner ChangeN/A
Ins Owners2.99%
Ins Owner ChangeN/A
Market Cap24.41M
Revenue(TTM)905.00K
Net Income(TTM)-9.42M
Analysts85.45
Price Target2.24 (117.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.13%
PT rev (3m)1.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.98%
EPS NY rev (3m)-18.39%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-23.01%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 26.97
P/FCF N/A
P/OCF N/A
P/B 3.51
P/tB 4.24
EV/EBITDA N/A
EPS(TTM)-0.53
EYN/A
EPS(NY)-0.35
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.04
BVpS0.29
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -65.45%
ROE -135.28%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-46.24%
ROA(5y)-42.87%
ROE(3y)-89.86%
ROE(5y)-84.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.01%
Cap/Sales 16.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.85
Quick Ratio 2.26
Altman-Z 1.27
F-Score3
WACC7.25%
ROIC/WACCN/A
Cap/Depr(3y)43.01%
Cap/Depr(5y)41.52%
Cap/Sales(3y)57.02%
Cap/Sales(5y)69.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.6%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.7%
EPS Next Y25.36%
EPS Next 2Y36.33%
EPS Next 3Y30.4%
EPS Next 5YN/A
Revenue 1Y (TTM)417.14%
Revenue growth 3Y4.86%
Revenue growth 5Y-21.79%
Sales Q2Q%309.29%
Revenue Next Year438.94%
Revenue Next 2Y313.66%
Revenue Next 3Y227.8%
Revenue Next 5YN/A
EBIT growth 1Y8.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.5%
EBIT Next 3Y37.33%
EBIT Next 5Y27.68%
FCF growth 1Y30.59%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y30.33%
OCF growth 3YN/A
OCF growth 5YN/A

VALBIOTIS SA / ALVAL.PA Fundamental Analysis FAQ

What is the fundamental rating for ALVAL stock?

ChartMill assigns a fundamental rating of 2 / 10 to ALVAL.PA.


What is the valuation status of VALBIOTIS SA (ALVAL.PA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VALBIOTIS SA (ALVAL.PA). This can be considered as Overvalued.


How profitable is VALBIOTIS SA (ALVAL.PA) stock?

VALBIOTIS SA (ALVAL.PA) has a profitability rating of 0 / 10.


What is the expected EPS growth for VALBIOTIS SA (ALVAL.PA) stock?

The Earnings per Share (EPS) of VALBIOTIS SA (ALVAL.PA) is expected to grow by 25.36% in the next year.